Capabilities
Active Pharmaceutical Ingredients
Product
Facilities
Finished Dose Formulations
Product
Facilities
Antimicrobial Solutions
Novel Medicine
Featured Portfolio
Antimicrobial Stewardship Program
Exblifep
Research
Fighting AMR
Fighting AMR
Antimicrobial Stewardships
Company
About us
Careers
Our thoughts
Investor
Contact
Contact
Stockexchanges
Investors Presentation Q1_FY24-25
August 13, 2024
Disclosure under Reg 30 of SEBI (LODR) Regulations, 2015_Monitoring Agency Report_June 30, 2024
August 13, 2024
Outcome of BM_August 12, 2024
August 12, 2024
Statement of Deviation Variation for Q1 ending_June 30 2024
August 12, 2024
Prior Intimation of Board Meeting_August, 2024
August 6, 2024
Newspaper Publication for AGM Notice_2024
July 28, 2024
Intimation of BRSR_2023-24
July 27, 2024
Intimation of AGM Notice and AR_2024
July 27, 2024
Revision in cut-off date for e-voting_AGM2024
July 25, 2024
Pre_31stAGM_Newspaper Advertisement_July 23, 2024
July 24, 2024
Certificate under Reg 76 of DP Regulation_June 30, 2024
July 24, 2024
Outcome of Adjourned Board Meeting_July 19, 2024
July 19, 2024
Outcome of Board Meeting_July 17, 2024
July 17, 2024
Certificate under Reg 74(5) of DP Regulation_June 30, 2024
July 16, 2024
Press Release- Orchid Pharma partners with Cipla to launch antibiotic Cefepime-Enmetazobactam in India
June 28, 2024
Trading Window Closure Intimation_June 30, 2024
June 27, 2024
Previous
1
...
Next
7 / 36